| scholarly article | Q13442814 |
| P2093 | author name string | Franz Y F Ho | |
| Kwok-pui Fung | |||
| Siu-kai Kong | |||
| Tim-tak Kwok | |||
| Wing-pui Tsang | |||
| P2860 | cites work | The 1995 Walter Hubert Lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene | Q36134953 |
| Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression | Q36551292 | ||
| A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis | Q40019792 | ||
| Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy | Q41113431 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 331-336 | |
| P577 | publication date | 2005-04-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis | |
| P478 | volume | 114 |
| Q28473504 | CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer |
| Q35080476 | Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53. |
| Q39572380 | Delayed caspase-8 activation and enhanced integrin β1-activated FAK underpins anoikis in oesophageal carcinoma cells harbouring mt p53-R175H. |
| Q42819037 | Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cells |
| Q35238838 | Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells |
| Q53741376 | GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability. |
| Q48863873 | Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide |
| Q39602480 | Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP. |
| Q39229754 | Mutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O(6)-methylguanine DNA-methyltransferase |
| Q46709821 | Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression |
| Q38197826 | Mutant p53 in cancer: new functions and therapeutic opportunities |
| Q38846785 | Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation |
| Q55346775 | Plakoglobin restores tumor suppressor activity of p53R175H mutant by sequestering the oncogenic potential of β-catenin. |
| Q24310790 | Role of p53/FAK association and p53Ser46 phosphorylation in staurosporine-mediated apoptosis: wild type versus mutant p53-R175H |
| Q35785051 | Salmonella enterica serovar enteritidis modulates intestinal epithelial miR-128 levels to decrease macrophage recruitment via macrophage colony-stimulating factor |
| Q37411955 | Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53 |
| Q35961417 | The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation. |
| Q35503066 | p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression |
Search more.